Protective Effect of Remote Ischemic Preconditioning against Myocardial Ischemia-Reperfusion Injury in Rats and Mice:

Lu Chen1, Yan Weng2, Ailing Qing3

  • 1Department of Anesthesiology, West China Hospital, Sichuan University, 610041 Chengdu, Sichuan, China.

Abstract

Insights

Remote ischemic preconditioning (RIPC) effectively protects against myocardial ischemia-reperfusion injury (MIRI) in animal models. Key factors like RIPC duration and site influence its protective effects, offering insights for human applications.

Area of Science:

  • Cardiology
  • Physiology
  • Pharmacology

Background:

  • Remote ischemic preconditioning (RIPC) demonstrates cardioprotective properties.
  • Myocardial ischemia-reperfusion injury (MIRI) remains a significant clinical challenge.

Purpose of the Study:

  • To evaluate the efficacy of RIPC in mitigating MIRI in rodent models.
  • To identify factors influencing RIPC's protective effects against MIRI.

Main Methods:

  • Systematic review and meta-analysis of 37 animal studies.
  • Inclusion of 713 male animals from PubMed, Web of Science, Embase, and Cochrane Library.
  • Assessment of myocardial infarct size, cardiac markers, and cell death using SYRCLE's Risk of Bias Tool.

Main Results:

  • RIPC significantly reduced infarct size, serum cardiac markers, and cell death in MIRI models.
  • Improved cardiac function was observed following RIPC.
  • RIPC duration and the specific site of preconditioning influenced its protective efficacy.

Conclusions:

  • RIPC offers robust protection against MIRI in small animal models.
  • Understanding influencing factors like duration and site is crucial for optimizing RIPC protocols.
  • Findings provide a basis for translating RIPC strategies to human clinical trials.

Related Concept Videos